ABI1 | Abl-interactor 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
ACKR3 | Atypical chemokine receptor 3 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
ACSL3 | Acyl-CoA synthetase long-chain family member 3 | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
AFF1 | AF4/FMR2 family, member 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
AFF3 | AF4/FMR2 family, member 3 | Cancer-related genes
| | | | | Mixed |
AFF4 | AF4/FMR2 family, member 4 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ALDH2 | Aldehyde dehydrogenase 2 family (mitochondrial) | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGAP26 | Rho GTPase activating protein 26 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ASPSCR1 | Alveolar soft part sarcoma chromosome region, candidate 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
BCL10 | B-cell CLL/lymphoma 10 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BCL3 | B-cell CLL/lymphoma 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
BCL7A | B-cell CLL/lymphoma 7A | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCL9 | B-cell CLL/lymphoma 9 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCOR | BCL6 corepressor | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BRD3 | Bromodomain containing 3 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BTG1 | B-cell translocation gene 1, anti-proliferative | Cancer-related genes Disease related genes
| | | | | Expressed in all |
C15orf65 | Chromosome 15 open reading frame 65 | Cancer-related genes
| | | | | Mixed |
C2orf44 | Chromosome 2 open reading frame 44 | Cancer-related genes
| | | | | Mixed |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CBFA2T3 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | Cancer-related genes Disease related genes
| | | | | Mixed |
CBFB | Core-binding factor, beta subunit | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | | | Mixed |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
CCNB1IP1 | Cyclin B1 interacting protein 1, E3 ubiquitin protein ligase | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Mixed |
CCND2 | Cyclin D2 | Cancer-related genes
| | | | | Mixed |
CCND3 | Cyclin D3 | Cancer-related genes
| | | | | Expressed in all |
CD274 | CD274 molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CDH11 | Cadherin 11, type 2, OB-cadherin (osteoblast) | Cancer-related genes Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |